Image source: Stockmonkeys.com via Flickr.Results from key trials under way at Novavax, Inc. (NASDAQ: NVAX), Agile Therapeutics (NASDAQ: AGRX), and Karyopharm Therapeutics (NASDAQ: KPTI) should be available soon, and if those results are positive, then these three companies could have blockbuster drugs on the market soon. Can these companies overcome the odds and deliver a win for investors?Continue reading